GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » 1-Year ROIIC %

Dermapharm Holding SE (LTS:0A5J) 1-Year ROIIC % : 15,854.44% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Dermapharm Holding SE 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Dermapharm Holding SE's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was 15,854.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Dermapharm Holding SE's 1-Year ROIIC % or its related term are showing as below:

LTS:0A5J's 1-Year ROIIC % is ranked better than
99.7% of 1010 companies
in the Drug Manufacturers industry
Industry Median: 1.6 vs LTS:0A5J: 15854.44

Dermapharm Holding SE 1-Year ROIIC % Historical Data

The historical data trend for Dermapharm Holding SE's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE 1-Year ROIIC % Chart

Dermapharm Holding SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 9.40 125.91 149.70 -6.18

Dermapharm Holding SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 -6.18 -71.02 -674.90 15,854.44

Competitive Comparison of Dermapharm Holding SE's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's 1-Year ROIIC % falls into.



Dermapharm Holding SE 1-Year ROIIC % Calculation

Dermapharm Holding SE's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 87.3355 (Sep. 2024) - 167.4004 (Sep. 2023) )/( 1836.399 (Sep. 2024) - 1836.904 (Sep. 2023) )
=-80.0649/-0.50499999999988
=15,854.44%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Dermapharm Holding SE  (LTS:0A5J) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Dermapharm Holding SE 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts, and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing, and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals, and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Dermapharm Holding SE Headlines

No Headlines